Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors

Michel D. Wissing, Janet Mendonca, Madeleine S.Q. Kortenhorst, Nadine S. Kaelber, Matthew Gonzalez, Eunice Kim, Hans Hammers, Paul J. Van Diest, Michael A. Carducci, Sushant K. Kachhap

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds